FDA Halt of Foreign Inspections May Delay Some New Product Approvals
March 11, 2020
Eric Palmer
FiercePharma
Axinn partner Chad Landmon was quoted in the FiercePharma article, "FDA Halt of Foreign Inspections May Delay Some New Product Approvals."
Click here to access the article.